Day: June 2, 2020

Montrouge, France, June 2, 2020DBV Technologies To Present at the Goldman Sachs 41stAnnual Global Healthcare ConferenceDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the Goldman Sachs 41st Annual Global Healthcare Conference, on Tuesday, June 9, 2020, at 1:20pm EST.A live webcast of the virtual presentation will be available on the Investors & Media section of the Company’s website: https://www.dbv-technologies.com/investor-relations/. A replay will be available on the DBV website for 30 days following the event.About DBV Technologies DBV Technologies is developing Viaskin®, an investigational proprietary technology platform with broad potential applications in immunotherapy....

Montrouge, France, le 2 juin (22 h 30 CEST) 2020DBV Technologies participera à la 41èmeGoldman Sachs Annual Global Healthcare ConferenceDBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq : DBVT), une société biopharmaceutique de stade clinique, a annoncé aujourd’hui que Daniel Tassé, Directeur Général de la société, interviendra lors de la 41ème Goldman Sachs Annual Global Healthcare Conference, le mardi 9 juin 2020, à 13h20 (heure locale) / 19h20 (heure de Paris).Une retransmission en direct de sa présentation sera disponible dans la section Investisseurs & Presse du site internet de la société : https://www.dbvtechnologies.com/investor-relations/. Une rediffusion de la présentation sera également disponible sur le site internet de DBV après l’événement.À propos de DBV TechnologiesDBV Technologies développe...

BALA CYNWYD, Pa., June 02, 2020 (GLOBE NEWSWIRE) — Private markets asset management firm Hamilton Lane Incorporated (NASDAQ: HLNE) (“Hamilton Lane”) today announced that it has commenced an underwritten public offering of 2,995,757 shares of Class A common stock, in the aggregate, to be sold by Hamilton Lane and three selling stockholders, subject to market and other conditions. Hamilton Lane intends to use the proceeds from the sale of its shares to settle in cash exchanges of membership units in Hamilton Lane Advisors, L.L.C. held by certain of its members.  Hamilton Lane will not receive any proceeds from the sale of shares by the selling stockholders.J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and underwriters for the offering.The offering is being made pursuant to an...

SÃO PAULO, Brazil, June 02, 2020 (GLOBE NEWSWIRE) — Arco Platform Limited, or Arco (Nasdaq: ARCE), announced today the commencement of an underwritten public offering of 5,563,203 Class A common shares to be offered by General Atlantic Arco (Bermuda), L.P and Alfaco Holding Inc.Arco will not receive any proceeds from the sale of Class A common shares by the Selling Shareholders. Neither Arco nor any other of its other shareholders, including its founding shareholders and members of management, are selling Class A common shares in this offering.Goldman Sachs & Co. LLC and Itau BBA USA Securities, Inc. are acting as underwriters in this public offering.The offering is being made only by means of a prospectus and related prospectus supplement forming part of a shelf registration statement on Form F-3 that was previously filed...

Media ReleaseThe U.S. FDA has notified Novartis that the agency has extended its review of the sBLA for subcutaneous ofatumumab in RMSRegulatory action in the U.S. now anticipated in September 2020Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has notified Novartis that the agency has extended its review of the supplemental Biologics License Application (sBLA) for subcutaneous ofatumumab for the treatment of relapsing forms of multiple sclerosis (RMS) in adults. Regulatory action in the U.S. is now anticipated in September 2020. Ofatumumab is being developed and marketed worldwide by Novartis under a license agreement between Genmab and Novartis Pharma AG.“As our partner Novartis works with the U.S. FDA to continue the review for subcutaneous ofatumumab in relapsing multiple sclerosis,...

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Gentor Resources Inc. (the “Company“) (TSX-V – “GNT”) announces that it has called an annual and special meeting of shareholders of the Company (the “AGM“) to be held on June 26, 2020.  At the AGM, shareholders of the Company will be asked to consider and, if thought advisable, to authorize by means of a special resolution, the consolidation of the issued and outstanding common shares of the Company (the “Common Shares“) by changing each two Common Shares into one Common Share.In the event that shareholders pass the said special resolution at the AGM to consolidate the Common Shares and the board of directors of the Company determines, in the best interests of the Company, to implement the share consolidation in order to assist in attracting...

OMAHA, Neb., June 02, 2020 (GLOBE NEWSWIRE) — Werner Enterprises, Inc. (Nasdaq: WERN), a premier transportation and logistics provider, today announced that Clarence L. Werner stepped down as its Executive Chairman effective May 31, 2020. Mr. Werner will continue to serve as Chairman of the board of directors through the end of his current term, which is expected to end in May 2021, and at that time it is expected that he will become Chairman Emeritus. In connection with this transition, the board of directors appointed Derek Leathers, the current Chief Executive Officer and President of the Company, as a member and Vice Chairman of the board of directors effective May 31, 2020. Mr. Werner has recommended to the board of directors that Mr. Leathers be named Chairman of the board of directors, in addition to Chief Executive Officer...

Festi announced 12 March 2020 that the company had received a notification from Arion banki under the market making agreement between the parties stating that the bank would activate a clause in the agreement permitting it to deviate from the conditions of the agreement in unforeseen circumstances.Arion banki has now notified Festi that despite the unforseen circumstances tha bank has met its obligations under the market making agreement in all aspects save the bid-ask spread. The bank is of the view that the circumstances no longer call for deviation from the agreement and its provisions relating to both bid-ask spread and price will be reactivated.For further information contact Eggert Þór Kristófersson, CEO of Festi (eggert@festi.is) or Magnús Kr. Ingason CFO of Festi (mki@festi.is).

CHANDLER, Ariz., June 02, 2020 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, announced today that the Company will present at the B of A Securities 2020 Global Technology Virtual Conference on Wednesday, June 3, 2020, at 1:45 p.m. (Pacific Time). Presenting for the Company will be Mr. Steve Sanghi, Chief Executive Officer, and Mr. Eric Bjornholt, Senior Vice President and Chief Financial Officer. A live webcast of the presentation will be made available by B of A, and can be accessed on the Microchip website at www.microchip.com.Any forward looking statements made during the presentation are qualified in their entirety by the discussion of risks set forth in the Company’s Securities and Exchange Commission filings. Copies...

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Sprott Focus Trust, Inc. (Nasdaq-FUND) (the “Fund” or “FUND”) has declared a quarterly distribution of $0.1093 per share on its Common Stock.  The distribution, optionally payable in additional shares of Common Stock or in cash by specific stockholder election, is to be paid on June 26, 2020 to stockholders of record at the close of business on June 15, 2020 (ex-dividend on June 12, 2020).  The price of shares issued for reinvestment will be determined on June 19, 2020.The Fund currently has adopted a Distribution Policy of paying quarterly distributions on its Common Stock.  Distributions are being made at the annual rate of 6% of the rolling average of the prior four calendar quarter-end net asset values (“NAVs”), with the fourth quarter distribution being the greater of 1.50% of the rolling...